Massmedica (WAR:MSM) Accounts Payable: zł8.35 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MSM Massmedica SA WAR:MSM
84 GF Score
Price zł4.50
GF Value zł4.31
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Massmedica Accounts Payable?

Massmedica WAR:MSM +2.27% 84 Accounts Payable is zł8.35 Mil as of Mar. 2026. GuruFocus rates WAR:MSM with a GF Score™ of 84/100 and a GF Value™ of zł4.31 (Fairly Valued). The stock has 4 warning signs investors should review.

Massmedica's Accounts Payable for the quarter that ended in Mar. 2026 was zł8.35 Mil.

Massmedica's quarterly Accounts Payable declined from Sep. 2025 (zł8.98 Mil) to Dec. 2025 (zł7.91 Mil) but then increased from Dec. 2025 (zł7.91 Mil) to Mar. 2026 (zł8.35 Mil).

Massmedica's annual Accounts Payable increased from Dec. 2023 (zł6.02 Mil) to Dec. 2024 (zł7.59 Mil) and increased from Dec. 2024 (zł7.59 Mil) to Dec. 2025 (zł7.91 Mil).

Massmedica Accounts Payable Historical Data

* Premium members only.

The historical data trend for Massmedica's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Massmedica Accounts Payable Chart

Massmedica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.44 9.10 6.02 7.59 7.91

Massmedica Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.96 8.52 8.98 7.91 8.35
WAR:MSM
84GF Score
Massmedica SA WAR:MSM
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Massmedica Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of zł8.35 Mil mean?
Massmedica (WAR:MSM) has a Accounts Payable of zł8.35 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Massmedica and its competitors.
Is Massmedica's Accounts Payable too high?
Massmedica's current Accounts Payable is zł8.35 Mil. Overall, Massmedica has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Massmedica's Accounts Payable compare to ABT and SYK?
Massmedica's Accounts Payable of zł8.35 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Massmedica and its competitors. Massmedica's current Accounts Payable is zł8.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Massmedica stock overvalued right now?
Based on GuruFocus' analysis, Massmedica (WAR:MSM) is currently considered Fairly Valued. The stock's GF Value™ is zł4.31, compared to a current price of zł4.50 — trading 4.4% above its estimated fair value. The current Accounts Payable is zł8.35 Mil. Massmedica's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Massmedica (WAR:MSM), the current Accounts Payable is zł8.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Massmedica (WAR:MSM) Overvalued in 2026?

Based on GuruFocus' analysis, Massmedica stock appears to be overvalued. The current stock price of zł4.50 is trading 4.4% above its estimated GF Value™ of zł4.31. GuruFocus considers Massmedica to be Fairly Valued.

Key valuation signals for WAR:MSM:

  • Accounts Payable: zł8.35 Mil
  • GF Value™: zł4.31 vs. price of zł4.50 (4.4% above fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the WAR:MSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Massmedica Business Description

Address ul. Adama Branickiego 17, Wilanow, Warsaw, POL, 02-972
Massmedica SA is operating in the areas of reconstructive, regenerative, anti-aging and aesthetic medicine. It deals in the distribution of implants and other medical materials used in the treatment of diseases of the musculoskeletal system and in regenerative medicine.
84GF Score

Get the complete analysis for WAR:MSM

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł4.50
Price
zł4.31
GF Value